Nestlé Set To Acquire Vitamins Company -- WSJ
December 06 2017 - 3:02AM
Dow Jones News
Purchase of Canada's Atrium Innovations comes as sales slow in
the food business
By Ben Dummett and Saabira Chaudhuri
This article is being republished as part of our daily
reproduction of WSJ.com articles that also appeared in the U.S.
print edition of The Wall Street Journal (December 6, 2017).
LONDON -- Nestlé SA agreed to buy Atrium Innovations Inc., a
Canadian vitamin maker, for $2.3 billion, including the assumption
of debt -- expanding its range of consumer-health offerings as
sales slow for packaged-food staples such as TV dinners and
chocolate-powdered drinks.
Atrium owns the Garden of Life and Pure Encapsulations
supplement brands and is owned by a consortium of investors led by
private-equity firm Permira. It will become part of Nestlé's
health-sciences arm, which makes products such as meal-replacement
drinks and nutritional therapies for conditions such as diabetes
and dysphagia.
That unit had sales of $15.2 billion last year, up 2% from the
previous year. Nestlé's overall sales last year were about $90
billion, most of that from businesses such as coffee, bottled
water, frozen food and candy bars.
Packaged-food makers such as Nestlé and Kraft Heinz Co. are
being buffeted by a number of forces. Fast-changing consumer tastes
have shoppers fleeing some of these companies' big brands in favor
of healthier options or locally or more naturally made goods.
Social media and e-commerce has leveled the playing field for
some of these small new competitors -- making the big companies'
research-and-development and marketing budgets less effective in
holding on to market share.
Earlier this year, Nestlé abandoned its long-held annual
sales-growth targets after years of missing them. A few months
later, activist investor Daniel Loeb took a $3.5 billion stake in
Nestlé, which makes Nescafe, Lean Cuisine and Nesquik, and demanded
big change.
In response, Nestlé Chief Executive Mark Schneider has rolled
out share buybacks and a formal profit-margin target. He also has
said he is willing to shuffle 10% of the company's portfolio. In
June, Nestlé put its North American chocolate business up for sale.
The unit could bring in $3 billion, according to analysts.
But mostly, Nestlé has focused on small acquisitions and stake
purchases since Mr. Schneider, a former health-care executive, took
over in January. The Vevey, Switzerland-based company in recent
months bought artisan coffee maker Blue Bottle, cold-brew coffee
brand Chameleon, and plant-based frozen foods maker Sweet Earth. It
took a stake in subscription meal-delivery company Freshly.
Greg Behar, Nestlé's head of health science, said buying Atrium
would allow Nestlé to extend its product range in areas such as
probiotics, plant-based protein nutrition, meal replacements and
multivitamins, including non-GMO, organic and natural supplements.
The Wall Street Journal first reported Nestlé's plans to buy Atrium
earlier Tuesday.
Montreal-based Atrium employs about 1,400 people. Its brands --
which also include the Wobenzym and Minami supplements -- are
distributed across more than 50 countries. Four years ago, Permira
said it was buying 75% of Atrium for about 563 million Canadian
dollars, or roughly US$444 million.
The selling consortium also included a group of Quebec-based
funds, including the pension fund Caisse de dépôt et placement du
Québec.
Write to Ben Dummett at ben.dummett@wsj.com and Saabira
Chaudhuri at saabira.chaudhuri@wsj.com
(END) Dow Jones Newswires
December 06, 2017 02:47 ET (07:47 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Nestle (PK) (USOTC:NSRGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nestle (PK) (USOTC:NSRGY)
Historical Stock Chart
From Apr 2023 to Apr 2024